Par Drugs & Chemicals Share Price

Par Drugs & Che.

CMP as on 05-Jul-22 10:08

₹ 190.55
20.35 11.96%


₹ 183.40

Turnover (lac)

₹ 587

Prev. Close

₹ 170.20

Day's Vol (shares)

₹ 3,07,938

Day's Range (₹)

₹ 181.50
₹ 196.40

Par Drugs and Chemicals Limited was originally incorporated as a private limited company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the company was converted into a public limited company pursuant to special resolution passed by the members in extra-ordinary general meeting of the company held on October 24, 2018 and the name of the company was changed to Par Drugs and Chemicals Limited on 5 November 2018.Vallabhbhai Savani and Sarita Savani were initial subscribers to the Memorandum of Association of the company. The Promoters of the company are Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani. The Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani have first shares on 19, 2006 through allotment of shares by company.The Company is engaged in the development and manufacture of Active Pharma ingredients (APIs) for the domestic market as well as for exports to international markets. APIs, also known as bulk drugs or bulk actives are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company produce various range of Antacid Molecules which are available in the market and are in great demand.The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.

  • Chairman & Managing Director

  • Executive Director & CEO

  • Whole-time Director

  • Director

    Shilpa Falgunbhai Savani
  • Director

    Nayna Jignesh Savani
  • Independent Director

    Kajal Chintanbhai Vaghani
  • Independent Director

    Krishna Mitulbhai Shah
  • Independent Director

    Pravin Manjibhai Bhayani
  • Company Secretary

    Sanket Bhupendrabhai Trivedi

Registered Office

805 Dwarkesh Complex,
RC Dutt Road Alkapuri,Vadodara,


5th Floor 506 to 508,